Kolexia
Reimund Jean-Marie Gastro-entérologie
Reimund Jean-Marie
Gastro-entérologie
Hopital Civil / Ihu
Strasbourg, France
91 Activités
91 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladie de Crohn Maladies inflammatoires intestinales Rectocolite hémorragique Colite Nécrose Tumeurs colorectales Tumeurs du côlon Anaphylaxie COVID-19

Collaborateurs

Voir plus
Caron Bénédicte
Caron Bénédicte
Hôpital Brabois, Vandoeuvre-lès-Nancy, France
Tambou-Nguimpi Marlène
Tambou-Nguimpi Marlène
Ctre Autonome D'endosc Digestive Ambul, Strasbourg, France
Laharie David
Laharie David
Hôpital Haut-lévêque, Pessac, France
Allez Matthieu
Allez Matthieu
Hôpital Saint-Louis, Paris, France

Industries

Voir plus
Janssen
6 collaboration(s)
Dernière en 2022
Pfizer
5 collaboration(s)
Dernière en 2021
Takeda Pharmaceutical
3 collaboration(s)
Dernière en 2023
Abbvie
2 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Prevalence and Determinants of Fatigue in Patients with IBD: A Cross-Sectional Survey from the GETAID.
Journal of Crohn's & colitis   20 octobre 2023
Obesity in adult patients with inflammatory bowel disease: Clinical features and impact on disability. A cross-sectional survey from the GETAID.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver   26 mai 2023
Fecal microbiota and bile acids in IBD patients undergoing screening for colorectal cancer.
Gut microbes   02 juin 2022
Prevalence of anti-TNF contraindications in Crohn's disease: A cross-sectional survey from the GETAID.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver   14 mai 2022
Survival and Predictive Factors of Chemotherapy With FOLFIRINOX as First-Line Therapy in Metastatic Pancreatic Cancer: A Retrospective Multicentric Analysis.
Pancreas   07 février 2022
P207 COVID-19: a prevalence rate two times lower than that of the general population in French patients with Inflammatory Bowel Disease treated with intravenous biologic agents
Abstracts of the 17th Congress of ECCO Virtual February 16-19, 2022   21 janvier 2022
Mesalazine initiates an anti-oncogenic β-catenin / MUCDHL negative feed-back loop in colon cancer cells by cell-specific mechanisms.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie   20 décembre 2021
ColonoScopy: Outcomes of Patients Who Had an Incomplete Colonoscopy After a Positive Fecal Immunological Test: Study of Practices in the Grand-Est
Essai Clinique (CHU Strasbourg)   10 décembre 2021
The IBD-disk Is a Reliable Tool to Assess the Daily-life Burden of Patients with Inflammatory Bowel Disease.
Journal of Crohn's & colitis   16 novembre 2021
Early Transmural Response Assessed Using Magnetic Resonance Imaging Could Predict Sustained Clinical Remission and Prevent Bowel Damage in Patients with Crohn's Disease Treated with Anti-Tumour Necrosis Factor Therapy.
Journal of Crohn's & colitis   01 septembre 2021